Clinical Trial Update: Granisetron Transdermal Patch System for Prevention of CINV by CapeOX [Phase 2]

View source ↗

Summary

Phase 2 trial update for granisetron transdermal patch to prevent chemotherapy-induced nausea and vomiting with CapeOX regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Granisetron transdermal patch (granisetron)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 2 | Status: UNKNOWN